---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-003002"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2022-03-07T23:59:59+00:00"
generated_at: "2026-06-27T01:06:48.861071+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biodesix enters $50M common stock purchase agreement with Lincoln Park Capital

## Summary
- Up to $50M of common stock may be sold to Lincoln Park over 36 months at Biodesix's discretion.
- Purchase price based on prevailing market prices with no upper limit per share.
- No warrants, derivatives, financial or business covenants; LPC cannot short or hedge.
- Biodesix issued commitment shares as a fee and can terminate the agreement at any time without cost.
- Net proceeds to be used for growth strategy and general corporate purposes.

## SEC filing metadata
- accession: 0000950170-22-003002
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2022-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000095017022003002/0000950170-22-003002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000095017022003002/bdsx-20220307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-003002
- JSON: https://secwatch.observer/filing/0000950170-22-003002.json
- Plain text: https://secwatch.observer/filing/0000950170-22-003002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.